DoddLEFollmannDWangJ, et al. Endpoints for randomized controlled clinical trials for COVID-19 treatments. Clin Trials2020; 17(5): 472–482.
2.
DeanNEGsellP-SBrookmeyerR, et al. Creating a framework for conducting randomized clinical trials during disease outbreaks. N Engl J Med2020; 382(14): 1366–1369.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.